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Abstract
Background:  Angiolymphoid hyperplasia with eosinophilia (ALHE) is a vasocentric process
characterized by infiltrates of lymphocytes and eosinophils, usually affecting the muscular arteries
of the head and neck. Currently it is unclear whether it is a reactive or neoplastic process.
Report: We present a 61-year-old African American male with a twenty year history of superficial
skin patches involving the head and neck region. An excisional biopsy of a right submental lymph
node revealed an atypical T-cell lymphocytic process, diagnosed as peripheral T-cell lymphoma
after immunophenotyping and molecular studies. Three months later the patient underwent a
biopsy of a left temporal nodule that was diagnosed as ALHE. Subsequently, at two year follow-up,
the patient was diagnosed with Mycosis Fungoides. Polymerase chain reaction for T cell receptor
gamma showed the same T-cell receptor gene rearrangement in both the temporal mass and the
right submental lymph node.
Conclusion: ALHE with molecular evidence of monoclonality is extremely unusual, as is the
association with nodal peripheral T-cell nodal lymphoma. The findings of this case support our
hypothesis that ALHE might be an early form of T-cell lymphoma.
Introduction
ALHE is characterized clinically by single to multiple red
brown dome shaped papules or subcutaneous nodules
located mainly in the head and neck [1-4]. In some cases
the nodules extend to the dermis or into the muscle.
About 1/5 of patients have blood eosinophilia and lym-
phadenopathy[2]. Histologically the lesions are character-
ized by a reactive proliferation of small blood vessels,
often surrounding a muscular artery, with peripheral
inflammatory infiltrates consisting of mononuclear cells
and eosinophils. The reactive blood vessels are often epi-
thelioid, leading to the terms "histiocytoid" or, more
recently "epithelioid" hemangioma[5]. Immunohisto-
chemical stains usually show a major population of T
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lymphocytes[6] with occasional B cells forming lymphoid
follicles[5]. Since the description of the initial large series
[5], there have been numerous reports of this condition,
with lesions occurring in a variety of organs, including dis-
seminated disease[1,7-13].
The etiology of ALHE is unknown. It is not clear if it is pri-
marily a vascular neoplasm, as suggested by an alternate
name (epithelioid hemangioma), a lymphoproliferative
process, or a heterogeneous group of entities. There is
some evidence that it may be related to traumatic pseu-
doaneurysm, supporting a vascular origin[14]. More
recent data suggest that ALHE may be a primary lympho-
proliferative process, as evidenced by findings of T-cell
gene rearrangements, although PCR analysis has not
shown monoclonality in all cases[15]. There has been a
single report of a patient with ALHE who subsequently
developed peripheral T-cell lymphoma [16]
The purpose of our study is to report the first documented
case of ALHE developing after the diagnosis of peripheral
T-cell lymphoma with T-cell receptor gene rearrangements
showing monoclonality in both the lymphoma and the
vascular lesion.
Case presentation
We present the case of a 61-years-old African American
male patient with history of hypertension and asthma.
The patient had a 20–30 year history of superficial skin
patches over the torso, and neck that over the five to six
years prior to the current presentation progressed to a dif-
fusely pruritic maculopapular rash with multiple subcuta-
neous skin nodules involving the head and neck region.
The patient reported that over in that period of time mul-
tiple biopsies of the nodules yielded nonspecific diag-
noses and was treated with doxycycline and dapsone
steroids. The largest nodule measured 3.5 × 2.5 cm and
was located on the left temporal scalp. A second nodule
on the right forehead measured 3.5 × 2.0 cm, multiple
smaller nodules were also noted.
The patient underwent a fine needle aspiration (FNA) of a
right submental nodule that revealed a T-cell lymphopro-
liferative disorder. An excisional biopsy was performed
which revealed a largely effaced lymph node with small
follicular centers, and marked paracortical expansion in a
background of macrophages and eosinophils (Figure 1).
Immunohistochemical markers show atypical cortical
lymphocytes that were positive for CD3, CD5, and CD43
and negative for CD7, CD15, CD20 and CD30. The small
follicular centers wee positive for CD20 and CD23. Flow
cytometry revealed CD45 dim lymphocytes expressing
CD2, CD3, CD4, CD5, and CD20 and were negative for
CD8, CD10, CD11c, CD16, CD19, CD25, CD23, CD38,
CD56, CD57, kappa and lambda. It was diagnosed as sus-
picious for T-cell lymphoma. CT scans demonstrated axil-
lary, inguinal and borderline hilar lymphadenopathy. A
complete blood count CBC revealed eosinophilia at 19%.
Three months later a biopsy of the left temporal nodule
revealed a muscular artery with medial disruption and
thrombosis, chronic inflammation and eosinophils. The
surrounding vascular proliferation had thick walls and
was notable for plump endothelial cells with hyperchro-
matic nuclei (Figure 2). The diagnosis of ALHE was ren-
dered. Ten months after the initial presentation the
patient presented with progressive lymphadenopathy. At
this time peripheral eosinophilia was also noted at 15.6%.
At twenty-two months follow up the patient was diag-
nosed with mycosis fungoides and began pentostatin
chemotherapy. The patient received six cycles with signif-
icant resolution of his pruritus and decrease in size of the
nodules. Subsequent CT scans demonstrated decreased
lymphadenopathy.
Tissue from the right submental nodule (T-cell lym-
phoma) as well as from the left temporal nodule (ALHE)
were analyzed by T cell receptor gene rearrangement stud-
ies and revealed identical monoclonal bands in TCR
gamma assay. In our internal validation studies, a mono-
clonal band was detected in 80% of T-cell lymphoma and
8.7% of B cell lymphoma in TCR gamma assay. Biclonal
monoclonal bands are not commonly seen in leukemia/
lymphoma cases. It occurs in less than 10% of leukemia/
lymphoma cases with clonality. There is no dominant
monoclonal band observed in IgH and TCR beta assays
for both specimen A and B.
Discussion
Angiolymphoid hyperplasia with eosinophilia (ALHE) is
a rare condition affecting muscular arteries, typically of
the head and neck[1]. It was first described in 1969 by
Wells and Whimster[4]. They reported nine patients
between the ages of 19 and 43, five women and four men,
with single to multiple lesions in the head and neck
region with blood eosinophillia in all patients and
regional lymphadenopathy in four of nine patients[4].
Previously it had been described as pseudo- or atypical
pyogenic granuloma, subcutaneous angioblastic lym-
phoid hyperplasia with eosinophilia, and papular angi-
oplasia[1,5]. Initially thought to be related to Kimura's
disease, a condition occurring in male Asians sharing
some of the same clinical and histological features, ALHE
is now considered a distinct entity[2,5,17,18].
In approximately 50% of cases, a muscular artery is at the
center of the lesion, as in our case report. Occasionally, in
such cases, the differential diagnosis is traumatic pseu-
doaneurysm, [19] although in the latter condition, theDiagnostic Pathology 2008, 3:22 http://www.diagnosticpathology.org/content/3/1/22
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lymphoid infiltrate and eosinophilic response is generally
minimal.
Although the lymphoid infiltrate is a prominent compo-
nent of ALHE, there are few data supporting a primarily
lymphoproliferative process for this condition. In a study
conducted by Jang et al[15], two of seven cases of ALHE
showed positive result for PCR analysis of rearranged
TCR-gene; however, all the cases were negative for heter-
oduplex-PCR[15]. The conclusion of these authors was
that the lymphoid reaction in ALHE is most likely reactive.
However, more recently, Kempf et al [2] demonstrated T-
cell gene rearrangements in 5 of 7 cases of ALHE and mon-
oclonality was confirmed by automated high-resolution
PCR fragment analysis. These authors raised the question
of whether ALHE or a subset of ALHE represents either a
true T-cell lymphoma of low-grade malignancy or a spe-
cific variant of reactive lymphoid hyperplasia [2]. In our
current case PCR analysis of the TCR-gene showed mono-
clonality between the peripheral T-cell lymphoma and the
ALHE specimens.
Further support that ALHE is a monoclonal T-cell process
is the finding of ALHE confirmed histologically in patients
with synchronous or metachronous T-cell lymphoma.
Adreae et al [16] reported a young girl with ALHE who
subsequently developed peripheral T-cell lymphoma
years after initial diagnosis. The current report demon-
strates a second case, in which the ALHE developed
months after the diagnosis of peripheral T-cell lym-
phoma. The finding of ALHE and peripheral T-cell lym-
phoma, and the demonstration of T cell gene
Peripheral T-cell lymphoma, unspecified (submental lymph node biopsy) Figure 1
Peripheral T-cell lymphoma, unspecified (submental lymph node biopsy). A, The H&E section demonstrates expansion of the 
interfollicular T-cells (low magnification); B. The infiltrating T-cells show atypia and clear cytoplasm (high magnification); C, Par-
affin immunoperoxidase staining reveals the lymphoma cells are positive for CD4; D. Reactive CD8-positive T-cells are also 
present.Diagnostic Pathology 2008, 3:22 http://www.diagnosticpathology.org/content/3/1/22
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rearrangements in both tissues, has not been previously
documented in a single patient.
Although the current patient supports the concept that
ALHE is, at least in some patients, reflected of a T-cell lym-
phoproliferative process, the finding of T-cell gene rear-
rangements indicated of monoclonality. According to
Kempf et al [2], clonal lesional lymphocytes cannot be
considered synonymous with malignant potency or overt
malignancy, but it does shed a new light on the pathoge-
netic aspects of this disorder.
In conclusion, we report a case of ALHE developing after
the diagnosis of peripheral T-cell lymphoma with T-cell
gene rearrangements studies showing monoclonality in
both the lymphoma and vascular lesions.
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Angiolymphoid hyperplasia with eosinophilia (vessel, temporal region, biopsy) Figure 2
Angiolymphoid hyperplasia with eosinophilia (vessel, temporal region, biopsy). A. Low magnification demonstrates a vessel wall 
infiltrated by small lymphoid cells. B. Higher magnification demonstrates a population of lymphoid cells with prominent vascu-
larity. C. There are focally increased eosinophils and reactive "epithelioid" endothelial cells. D. The atypical lymphoid cells show 
small amount of clear cytoplasm with scattered eosinophils in the background.Publish with BioMed Central    and   every 
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